Who Paid My Doc
Allison Eckard
Pediatric Infectious Diseases Charleston, SC Medical Doctor
NPI 1922212968 CMS profile 873509
171 Ashley Ave, Charleston, SC 29425
General payments
$31,157
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Allison Eckard of Charleston, SC is reported in the CMS Open Payments database as having received $31,157 across 23 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 88th percentile of Pediatric Infectious Diseases profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
4 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $8,071 | 3 | |
| 2023 | General | $2,855 | 2 | |
| 2021 | General | $2,000 | 2 | |
| 2019 | General | $18,231 | 16 |
Beside peers
- Allison Eckard
- Pediatric Infectious Diseases median
- Middle half of Pediatric Infectious Diseases
- National median
In program year 2025, general payments to Allison Eckard were reported at $8,071. Among 311 Pediatric Infectious Diseases profiles paid that year, the median was $126 and the middle half received between $41 and $2,094.
Show as a table
| Year | Allison Eckard | Pediatric Infectious Diseases median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $18,231 | $175 | $34–$2,175 | $163 |
| 2020 | $0 | $521 | $34–$6,009 | $114 |
| 2021 | $2,000 | $1,077 | $39–$4,557 | $132 |
| 2022 | $0 | $232 | $53–$6,196 | $149 |
| 2023 | $2,855 | $140 | $52–$4,662 | $160 |
| 2024 | $0 | $198 | $52–$3,860 | $164 |
| 2025 | $8,071 | $126 | $41–$2,094 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 12 drugsPart D claims
212
Drug cost
$651,167
Branded share of claims
88.2%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Trogarzo Ibalizumab-Uiyk | Brand | 32 | $223,036 | |
| Rukobia Fostemsavir Tromethamine | Brand | 13 | $117,725 | |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | Brand | 23 | $87,697 | |
| Tivicay Dolutegravir Sodium | Brand | 21 | $72,327 | |
| Delstrigo Doravirine/Lamivu/Tenofov Diso | Brand | 22 | $56,235 | |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | Brand | 13 | $55,123 | |
| Prezista Darunavir | Brand | 16 | $28,823 | |
| Norvir Ritonavir | Brand | 16 | $7,408 | |
| Famotidine | Generic | 13 | $1,428 | |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | Brand | 17 | $1,283 |
The 10 drugs with the highest cost, of 12 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 5,546 Part D prescribers listed as Infectious Disease; they describe a distribution and say nothing about conduct.
Records
23 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Pediatric Infectious Diseases in South Carolina
Sandra Fowler
Pediatric Infectious Diseases · Charleston, SC
Anna Kathryn Burch
Pediatric Infectious Diseases · Columbia, SC
Rebecca Widener
Pediatric Infectious Diseases · Columbia, SC
Markus Buchfellner
Pediatric Infectious Diseases · Charleston, SC
Katherine Richardson
Pediatric Infectious Diseases · Greenville, SC
Sue Jue
Pediatric Infectious Diseases · Greenville, SC
Related records
Pediatric Infectious Diseases in South Carolina
Practitioners in the same specialty and state, ranked by reported value.
All Pediatric Infectious Diseases
Everyone recorded under this specialty, nationwide.
Doctors in South Carolina
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.